| ALCON AG NAM. SF -,04 |
| Schweiz |
| Gesundheit |
| CH0432492467 / A2PDXE |
| 2U3 (Frankfurt) / ALC (NYSE) |
| FRA:2U3, ETR:2U3, 2U3:GR, NYSE:ALC |
| SMI |
| https://www.alcon.com/ |
|
Alcon Inc. is a leading global company specializin..
>Volltext.. |
| 37894.2 Mio. EUR |
| 41407.68 Mio. EUR |
| 8516.23 Mio. EUR |
| 2375.21 Mio. EUR |
| 961.12 Mio. EUR |
| 1.94 EUR |
| 4454.61 Mio. EUR |
| 1208.67 Mio. EUR |
| 1808.66 Mio. EUR |
| 0.63 |
| 5.61% |
| 8.82% |
| - |
| 0.4% |
| 0.39% |
| 10.05.23 - 0.22444798€ 03.05.22 - 0.21376€ >weitere anzeigen... |
| - |
| ALCON |
| 19.08.25 |
|
||||
|
||||
|
||||
|
||||
|
||||
|